Elliot DeHaan - Concepedia

Author

Elliot DeHaan

Also Known As

Elliot DeHaan, Elliot N DeHaan, Elliot N. DeHaan, Emily Degan, Shashi Kapadia

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Elliot DeHaan is an author at Harvard University specializing in autoimmunity, medicine, and host resistance.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	283
2	Immunology	1	1	283
3	Autoimmune Disease	1	1	283
4	Autoimmunity	1	1	283
5	Host-pathogen Interactions	1	1	283

Elliot DeHaan

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults Edward E. Walsh, Gonzalo Pérez Marc, Agnieszka Zareba, New England Journal of Medicine	2023	574
SDF-1α induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells Robyn S. Klein, Joshua B. Rubin, Hilary D. Gibson, Development	2001	294
IP-10 Is Critical for Effector T Cell Trafficking and Host Survival in Toxoplasma gondii Infection Imtiaz A. Khan, James A. MacLean, Frederick S. Lee, Immunity Toxoplasma Gondii InfectionHost ResponseHost SurvivalAutoimmune DiseasePathogenesis	2000	283
Signal Transducer and Activator of Transcription 6 Controls Chemokine Production and T Helper Cell Type 2 Cell Trafficking in Allergic Pulmonary Inflammation Anuja Mathew, James A. MacLean, Elliot DeHaan, The Journal of Experimental Medicine	2001	180
CC Chemokine Receptor-2 Is Not Essential for the Development of Antigen-Induced Pulmonary Eosinophilia and Airway Hyperresponsiveness James A. MacLean, George T. De Sanctis, Kate G. Ackerman, The Journal of Immunology	2000	35
Risk of COVID-19 after natural infection or vaccination Anne-Marie Rick, Matthew B. Laurens, Ying Huang, EBioMedicine	2023	13
Bivalent RSVpreF Vaccine in Adults 18 to &lt;60 Years Old With High-Risk Conditions William Towner, Elliot DeHaan, Qin Jiang, Clinical Infectious Diseases	2024	13

Page 1